Try our Advanced Search for more refined results

IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

Track this case

Case overview

Case Number:

2:16-md-02724

Court:

Pennsylvania Eastern

Nature of Suit:

Other Statutes: Anti-Trust

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

CYNTHIA M. RUFE

Firms

Companies

Government Agencies

Sectors & Industries:

  1. December 19, 2018

    Generic-Drug Cos. Want AGs To Shut Up About Price-Fixing

    Generic-drug companies facing multidistrict litigation and ongoing probes into alleged price-fixing are tired of hearing about them in the news, according to a brief filed in Pennsylvania federal court Tuesday that argues state attorneys general offices have violated legal and ethical requirements to keep mum.

  2. November 15, 2018

    Judge Won't Quash AGs' Subpoenas In Generic Pricing MDL

    The New York and Connecticut attorneys general can keep sending subpoenas to drugmakers as part of their broader investigations into generic-drug price-fixing, a Pennsylvania federal judge has ruled, despite the drug companies’ concern the investigations were circumventing the discovery process for a sprawling multidistrict litigation.

  3. November 05, 2018

    Humana Seeks Case's Inclusion In Generic Price-Fixing MDL

    Humana on Friday asked the Pennsylvania federal court overseeing the sprawling multidistrict litigation over generic drug prices to formally incorporate its action into the MDL, saying its claims target many of the same drugs that the group of states and proposed classes of drug buyers are targeting.

  4. October 17, 2018

    20 Drugmakers Must Face Generic Price-Fixing MDL

    A Pennsylvania federal court has greenlighted the first round of multidistrict litigation accusing more than 20 generic-drug makers of conspiring to fix their prices, excusing only Teligent Inc. from the antitrust litigation.

  5. September 26, 2018

    McKesson Is Roped Into Generic-Drug Price-Fixing Row

    McKesson Corp. earned billions of dollars by cooperating with an industrywide price-fixing conspiracy among generic-drug makers, according to a proposed class action Tuesday that appeared to be one of the first suits linking a drug distributor to multidistrict litigation over alleged drugmaker collusion.

  6. January 03, 2018

    Generics Buyers Fight To Keep 2 Drugs In Antitrust MDL

    Direct purchaser plaintiffs in a large antitrust class action alleging price-fixing of a variety of generic drugs are pushing back against a motion to dismiss claims over two drugs, telling a Pennsylvania federal judge that the complaints contain more than enough of a basis to open discovery.

  7. November 15, 2017

    State AGs Want Separate Track In Generic Price-Fixing MDL

    State attorneys general accusing 18 drug companies of conspiring to fix the prices of 15 generic drugs urged a Pennsylvania federal judge Tuesday to establish a separate government track within the broader multidistrict litigation, saying they can't yield authority to other entities such as private parties' lead counsel and their allegations are too broad to be litigated drug by drug.

  8. October 31, 2017

    State AGs Triple Size Of Generic Price-Fixing Litigation

    The 46 attorneys general accusing six drug companies of conspiring to fix the price of two generic drugs said Tuesday they're asking a Pennsylvania federal court for permission to massively expand their suit by targeting 12 more drug companies, 13 more drugs, and Mylan and Emcure executives.

  9. June 02, 2017

    6 Suits Say Mylan, Others Rigged Generic Drug Prices

    Mylan Inc., Fougera Pharmaceuticals Inc., Par Pharmaceuticals Inc. and other drugmakers conspired to jack up the prices of certain generic muscle relaxers, skin creams, antidepressants and blood pressure drugs, a Northeast U.S. pharmacy operator said in six separate antitrust lawsuits filed on Thursday as part of multidistrict litigation in Pennsylvania federal court.

  10. May 23, 2017

    Generic Drug Price-Fixing MDL Fuels Worries For Defendants

    The multidistrict litigation over alleged price-fixing of generic drugs recently consolidated in Pennsylvania's Eastern District has the potential to emerge as one of the thorniest court fights in the country, and some observers have raised concerns that the numerous defendants could make it harder for individual companies to avoid getting more deeply embroiled in the litigation.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!